X @Investopedia
Investopedia·2025-06-24 21:00
Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment. https://t.co/TKzaDx0l0W ...
Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment. https://t.co/TKzaDx0l0W ...